← FDA DRUG APPROVALS

FDA NDA · NDA003718

SYNKAYVITE

Sponsor: ROCHE

APPLICATION
NDA003718
TYPE
NDA
ORIGINAL APPROVAL
1941-07-15
LATEST ACTION
1996-03-27
ROUTE
INJECTION, ORAL
DOSAGE FORM
INJECTABLE, TABLET
MARKETING STATUS
Discontinued

Products

SYNKAYVITEDiscontinued
MENADIOL SODIUM DIPHOSPHATE 5MG/ML · INJECTABLE · INJECTION
SYNKAYVITEDiscontinued
MENADIOL SODIUM DIPHOSPHATE 5MG · TABLET · ORAL
SYNKAYVITEDiscontinued
MENADIOL SODIUM DIPHOSPHATE 37.5MG/ML · INJECTABLE · INJECTION
SYNKAYVITEDiscontinued
MENADIOL SODIUM DIPHOSPHATE 10MG/ML · INJECTABLE · INJECTION

Approval history

1996-03-27Labeling · Supplement 7AP
1996-03-27Labeling · Supplement 4AP
1987-09-08Labeling · Supplement 8AP
1941-07-15UNKNOWN · Original · unknownAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →